Focus on drug price reform in the first half of 2015

Source: more than half of China news.com's 2015-7-2 year, medical reform is still a hot topic From the point of view of the first half of the medical reform, local governments focused on the problem of high drug prices in public hospitals Among them, the market-oriented reform of drug pricing at the beginning of May attracted wide discussion Experts in the industry analyzed that the drug price reform also needs to cooperate with medical supervision and medical insurance payment to achieve three medical linkage On May 5, the national health and Family Planning Commission issued the notice on printing and distributing opinions on promoting drug price reform, which decided to cancel most of the drug government pricing, improve the drug purchase mechanism and play the role of medical insurance fee control from June 1, 2015 The actual transaction price of drugs is mainly formed by market competition In this regard, hospitals, pharmaceutical enterprises, citizens and other stakeholders have shown great concern People in the pharmaceutical industry believe that the price of drugs should be stable in the short term, and may decline in the long term At the same time, liberalizing the price does not mean giving up the supervision of drugs, but to adopt the way of "combination of releasing and management", and the focus of the government's function will turn to the supervision in the event and afterwards Now, the implementation of the notice has been full moon Recently, China new network health channel visited many pharmacies in Beijing and learned that the overall price of drugs tends to be stable without major adjustment A staff member of Jinxiang pharmacy said that no notice about the price adjustment of drugs had been received recently Guo, a Beijing resident in his 80s, has high blood pressure and needs to take antihypertensive drugs such as loxorubicin, losartan potassium tablets and bisoprolol fumarate for a long time He told China new network health channel that since the implementation of the "6.1 New Deal", he has not felt the obvious change in drug prices The cost of taking medicine is still more than 90 yuan after reimbursement by medical insurance " After the market-oriented reform of drug price pricing, the national health and Family Planning Commission on June 19, in response to the specific problems such as the false high drug price, the disconnection between hospital drug bidding and procurement, and the increasingly difficult purchase of low-cost drugs The notice on implementing and improving the guiding opinions on centralized drug purchase in public hospitals was issued on July, proposing to build a new mechanism for centralized drug purchase in an all-round way Drug purchase will be divided into five categories: bidding for drug purchase, negotiation for drug purchase, direct online purchase of drugs, national designated production of drugs, narcotic drugs and the first category of psychotropic drugs, and a new round of drug concentration will be launched within the year Procurement Experts believe that the classified bidding of the notice is conducive to ensure that the drug price returns to a reasonable range, which will not only reduce the burden of patients, but also promote the reform of public hospital service system However, the industry has also said that it is not only the drug price that affects patients' feelings of seeing a doctor, but also the cost of seeing a doctor If the cost is very high, even if the drug price is no lower, people will not be satisfied The director of the International Research Center for pharmaceutical management of Peking University told the media that centralized procurement and even drug price reform cannot be the policy Island, so it is necessary to truly realize the linkage of three medical services, pay attention to the supervision of medical behaviors, and strengthen the rational and standardized use of drugs by medical institutions; at the same time, implement the reform of medical insurance payment mode, and strengthen the policy cooperation between medical insurance payment and drug purchase We should also increase the income of medical workers Original detailed address: http://news.pharmnet.com.cn/news/2015/07/01/423275-1.html